General Information of the Compound
| Compound ID |
CP0848535
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5'-(Trimethylammonium)methyl-17-cyclopropylmethyl-6,7-didehydro-4,5alpha-epoxy-3,14-dihydroxyindolo[2',3':6,7]morphinan Iodide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H36IN3O3
|
||||||||||||||||||
| Molecular Weight |
613.54
|
||||||||||||||||||
| Canonical SMILES |
C[N+](C)(C)Cc1ccc2[nH]c3c(c2c1)C[C@@]1(O)C2Cc4ccc(O)c5c4[C@@]1(CCN2CC1CC1)[C@H]3O5.[I-]
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H35N3O3.HI/c1-33(2,3)16-18-6-8-22-20(12-18)21-14-30(35)24-13-19-7-9-23(34)27-25(19)29(30,28(36-27)26(21)31-22)10-11-32(24)15-17-4-5-17;/h6-9,12,17,24,28,31,35H,4-5,10-11,13-16H2,1-3H3;1H/t24?,28-,29-,30+;/m0./s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
HYODZNRRRUZOCU-RLCBAZDTSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01526, Delta-type opioid receptor
Protein ID: PT01460, Kappa-type opioid receptor
Protein ID: PT01549, Mu-type opioid receptor